3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs

PHASE3CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Post-menopausal Osteoporosis
Interventions
DRUG

Placebo

DRUG

Zoledronic acid

Trial Locations (57)

1023

Novartis Investigative Site, Budapest

1083

Novartis Investigative Site, Budapest

1085

Novartis Investigative Site, Budapest

2065

Novartis Investigative Site, St Leonards

2317

Novartis Investigative Site, Hamar

3000

Novartis Investigative Site, Leuven

3010

Novartis Investigative Site, Bern

3052

Novartis Investigative Site, Parkville

3220

Novartis Investigative Site, Geelong

4012

Novartis Investigative Site, Debrecen

5094

Novartis Investigative Site, Bergen

8091

Novartis Investigative Site, Zurich

8230

Novartis Investigative Site, Balatonfüred

9000

Novartis Investigative Site, Ghent

9023

Novartis Investigative Site, Győr

12200

Novartis Investigative Site, Berlin

15261

Novartis Investigative Site, Pittsburgh

16011

Novartis Investigative Site, Arenzano

23249

Novartis Investigative Site, Richmond

30167

Novartis Investigative Site, Hanover

30501

Novartis Investigative Site, Gainesville

35128

Novartis Investigative Site, Padua

35619

Novartis Investigative Site, Braunfels

37067

Novartis Investigative Site, Valeggio sul Mincio

39110

Novartis Investigative Site, Magdeburg

40002

Novartis Investigative Site, Khonkaen

46202

Novartis Investigative Site, Indiamapolis

50200

Novartis Investigative Site, Chaingmai

53100

Novartis Investigative Site, Siena

58103

Novartis Investigative Site, Fargo

69003

Novartis Investigative Site, Lyon

80227

Novartis Investigative Site, Lakewood

80809

Novartis Investigative Site, München

87106

Novartis Investigative Site, Albuquerque

98144

Novartis Investigative Site, Seattle

92103-6204

Novartis Investigative Site, San Diego

04401

Novartis Investigative Site, Bangor

C1117ABH

Novartis Investigative Site, Buenos Aires

C1221ADC

Novartis Investigative Site, Caba

B1878DVB

Novartis Investigative Site, Quilmes

V5Z 2K4

Novartis Investigative Site, Vancouver

H3A 1A1

Novartis Investigative Site, Montreal

G1v 3M7

Novartis Investigative Site, Sainte-Foy

Unknown

Novartis Investigative Site, Barranquilla

Novartis Investigative Site, Bogotá

Novartis Investigative Site, Medellín

Novartis Investigative Site, Hong Kong

Novartis Investigative Site, Grafton

00100

Novartis Investigative Site, Helsinki

0050

Novartis Investigative Site, Oslo

0176

Novartis Investigative Site, Oslo

04-730

Novartis Investigative Site, Warsaw

15-337

Novartis Investigative Site, Bialystok

00-416

Novartis Investigative Site, Warsaw

02-341

Novartis Investigative Site, Warsaw

413 45

Novartis Investigative Site, Gothenburg

SE-171 76

Novartis Investigative Site, Stockholm

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY